PUBLISHED VERSION - University of Adelaide · 2019. 8. 30. · REPORT CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)